The latest immunotherapy news and developments
PULSAR-integrated radiotherapy with immunotherapy for improved tumour control
Artificial intelligence, along with a $71-million expansion of Radiation Oncology services, is allowing UT Southwestern…
Browsing: Immunotherapy
Model to predict non-small cell lung cancer patient outcomes to immunotherapy developed
Immunotherapy agents that inhibit the molecules PD1, PD-L1 or CTLA-4 have become widely used in…
Immunotherapy may be effective for a subgroup of metastatic colorectal cancer patients
Researchers at City of Hope, USA, looked at the most common type of metastatic colorectal…
Why nanoparticles could prove a game changer for cancer immunotherapy
The major goal of cancer therapy is to destroy cancer cells while sparing the surrounding,…
Increasing the immune system’s appetite for cancer protectors
A two-arm molecule can effectively deplete cancer-protecting cells inside tumours, allowing the immune system to…
Using viruses to discover cancer drug resistance mutations
Using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on…
Cancer treatments didn’t falter in Australia during 2020 COVID-19 lockdowns
The findings come as welcome news as NSW lockdowns continue – but future cancer treatment patterns…
Scoring system predicts head and neck cancer patient response to immunotherapy
A prognostic scoring system that is cheap, efficient and reliable can predict how patients with…
Study identifies biomarker for breast cancer response to immunotherapy
A biomarker that has proven to be a predictor for response to immunotherapies in melanoma…
Personalised immunotherapy: Rapid screening of therapeutic combinations
An innovative testing platform that more closely mimics what cancer encounters in the body may…